X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Pharmacovigilance Companies (2024 - 2029)

Several companies in the technology and healthcare sectors are making significant strides in their respective fields. These firms, which range from global corporations to innovative startups, are leveraging cutting-edge technology and strategic partnerships to drive growth and deliver value to their stakeholders. These companies are characterized by their commitment to innovation, customer-centric approach, and robust operational capabilities, enabling them to navigate the complexities of the market and maintain a competitive edge. With their diverse portfolio of products and services, these businesses are well-positioned to address the evolving needs of their customers and create a positive impact in their respective industries.

Home Market Analysis Healthcare Research Healthcare IT Research Healthcare Payer Solutions Research Pharmacy Analysis Research Pharmacovigilance Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Pharmacovigilance Market

This report lists the top Pharmacovigilance companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Pharmacovigilance industry.

  1. Cognizant

  2. Capgemini

  3. Accenture

  4. Wipro

  5. IBM

*Disclaimer: Top companies sorted in no particular order

Pharmacovigilance Market Major Players

Pharmacovigilance Market Concentration

Pharmacovigilance Market Concentration

Pharmacovigilance Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Drug Consumption and Drug Development Rates

      2. 4.2.2 Growing Incidence Rates of Adverse Drug Reaction and Drug Toxicity

      3. 4.2.3 Increasing Trend of Outsourcing Pharmacovigilance Services

    3. 4.3 Market Restraints

      1. 4.3.1 High Risk Associated with Data Security

      2. 4.3.2 Lack of Global Regulatory Harmonization and Lack of Data Standardization for Adverse Event Collection

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Billion)

    1. 5.1 By Clinical Trial Phase

      1. 5.1.1 Preclinical

      2. 5.1.2 Phase I

      3. 5.1.3 Phase II

      4. 5.1.4 Phase III

      5. 5.1.5 Phase IV

    2. 5.2 By Service Provider

      1. 5.2.1 In-house

      2. 5.2.2 Contract Outsourcing

    3. 5.3 By Type of Reporting

      1. 5.3.1 Spontaneous Reporting

      2. 5.3.2 Intensified ADR Reporting

      3. 5.3.3 Targeted Spontaneous Reporting

      4. 5.3.4 Cohort Event Monitoring

      5. 5.3.5 EHR Mining

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Pharmaceutical Companies

      3. 5.4.3 Other End Users

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Accenture

      2. 6.1.2 ArisGlobal

      3. 6.1.3 BioClinica

      4. 6.1.4 Capgemini

      5. 6.1.5 Cognizant

      6. 6.1.6 IBM Corporation

      7. 6.1.7 ICON PLC

      8. 6.1.8 IQVIA

      9. 6.1.9 ITClinical

      10. 6.1.10 Laboratory Corporation of America Holdings

      11. 6.1.11 Linical Accelovance

      12. 6.1.12 PAREXEL International Corporation

      13. 6.1.13 United BioSource Corporation

      14. 6.1.14 TAKE Solutions Ltd

      15. 6.1.15 Wipro Ltd

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Pharmacovigilance Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Pharmacovigilance Market Companies Summary

The pharmacovigilance market is seeing significant growth due to the rising incidence of adverse drug reactions and safety issues, particularly amid the COVID-19 pandemic. The development of vaccines has created new challenges, such as post-authorization safety monitoring and vaccine safety communication, leading to an increased demand for pharmacovigilance services. The growth of the market is further propelled by increasing drug consumption and development rates, growing incidence rates of adverse drug reactions and drug toxicity, and a rising trend of outsourcing pharmacovigilance services. The need for regular monitoring of drugs has also increased due to the growing drug consumption, thereby boosting the pharmacovigilance market. Pharmaceutical firms are expected to hold a major market share in the pharmacovigilance market due to the rising adoption of pharmacovigilance services. The growing need for medical information by regulatory authorities is also anticipated to fuel the growth of this sector. Furthermore, the significance of post-marketing medication evaluation in better characterizing drug safety profiles in real-world settings is also driving market growth. Moreover, collaborations between pharmaceutical firms and software providers in the market are further expected to propel market growth. However, factors such as high risk associated with data security, lack of global regulatory harmonization, and lack of data standardization for adverse event collection, may hinder the growth of the pharmacovigilance market.

Explore More

Pharmacovigilance Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Accenture

      2. 1.1.2 ArisGlobal

      3. 1.1.3 BioClinica

      4. 1.1.4 Capgemini

      5. 1.1.5 Cognizant

      6. 1.1.6 IBM Corporation

      7. 1.1.7 ICON PLC

      8. 1.1.8 IQVIA

      9. 1.1.9 ITClinical

      10. 1.1.10 Laboratory Corporation of America Holdings

      11. 1.1.11 Linical Accelovance

      12. 1.1.12 PAREXEL International Corporation

      13. 1.1.13 United BioSource Corporation

      14. 1.1.14 TAKE Solutions Ltd

      15. 1.1.15 Wipro Ltd

    2. *List Not Exhaustive

Pharmacovigilance Companies FAQs

Cognizant, Capgemini, Accenture, Wipro Limited and IBM are the major companies operating in the Pharmacovigilance Market.

Pharmacovigilance Market Report Snapshots

Pharmacovigilance Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)